Variation of PPARG Expression in Chemotherapy-Sensitive Patients of Hypopharyngeal Squamous Cell Carcinoma

Table 2

Clinical data of HSCC patients for GSE85607.

Subject ID	Gender	Age	TNM stage	Histologic differentiation degree	Chemotherapy response
S1	Female	71	T2N0M0	Poorly differentiated	PR
S2	Male	68	T2N0M0	Well differentiated	PR
S3	Male	55	T4aN0M0	Well differentiated	PR
S4	Male	68	T3N0M1	Moderately differentiated	PR
S5	Male	58	T3N0M0	Well differentiated	PR
S6	Male	52	T2N0M0	Well differentiated	PR
S7	Male	56	T2N0M0	Well differentiated	PR
N1	Male	58	T4aN3M0	Poorly differentiated	SD
N2	Male	61	T3N2M0	Poorly differentiated	SD
N3	Male	56	T1N0M0	Well differentiated	SD
N4	Male	59	T3N2M0	Moderately differentiated	PD

Note: CR (complete response): disappearance; confirmed at 4 weeks; PR (partial response): 50% decrease; confirmed at 4 weeks; SD (stable disease): neither PR nor PD criteria are met; PD (progressive disease): 25% increase; no CR, PR, or SD documented before a progressed disease.